{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:26:17Z","timestamp":1769693177015,"version":"3.49.0"},"reference-count":56,"publisher":"Begell House","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Immunol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1615\/critrevimmunol.2022045288","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T18:52:38Z","timestamp":1660243958000},"page":"13-19","source":"Crossref","is-referenced-by-count":4,"title":["Liquid Biopsy and Its Emerging Role in Rheumatology"],"prefix":"10.1615","volume":"42","author":[{"given":"Marta","family":"\u015awiecka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ma\u015bli\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"issue":"2","key":"1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40291-019-00444-8","article-title":"Liquid biopsy applications in the clinic","volume":"24","author":"Chen D.","year":"2020","journal-title":"Mol Diagn Ther"},{"key":"2","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918794630","article-title":"Liquid biopsy of cancer: A multimodal diagnostic tool in clinical oncology","volume":"10","author":"Palmirotta R.","year":"2018","journal-title":"Ther Adv Med Oncol"},{"issue":"8","key":"3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid biopsy: Monitoring cancer-genetics in the blood","volume":"10","author":"Crowley E.","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"4","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.03.008","article-title":"Liquid biopsy in chronic liver disease","volume":"20","author":"Barrera-Saldana H.A.","year":"2021","journal-title":"Ann Hepatol"},{"issue":"12","key":"5","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.7150\/thno.45554","article-title":"Liquid biopsy for infectious diseases: A focus on microbial cell-free DNA sequencing","volume":"10","author":"Han D.","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.diagmicrobio.2018.06.009","article-title":"Liquid biopsy for infectious diseases: Sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease","volume":"92","author":"Hong D.K.","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/14737159.2020.1777859","article-title":"Liquid biopsy markers for stroke diagnosis","volume":"20","author":"Wijerathne H.","year":"2020","journal-title":"Expert Rev Mol Diagn"},{"issue":"9","key":"8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/gt.2017.77","article-title":"Human genomics projects and precision medicine","volume":"24","author":"Carrasco-Ramiro F.","year":"2017","journal-title":"Gene Ther"},{"issue":"5","key":"9","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: A meta-analysis based on a systematic review","volume":"41","author":"Almutairi K.","year":"2021","journal-title":"Rheumatol Int"},{"issue":"1","key":"10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis","volume":"31","author":"Deane K.D.","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105887","article-title":"A review of liquid biopsy as a tool to assess epigenetic, cfDNA and miRNA variability as methotrexate response predictors in patients with rheumatoid arthritis","volume":"173","author":"Daraghmeh D.N.","year":"2021","journal-title":"Pharmacol Res"},{"issue":"9","key":"12","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha D.","year":"2010","journal-title":"Arthritis Rheumat"},{"key":"13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2018.07.004","article-title":"Liquid biopsies to guide therapeutic decisions in rheumatoid arthritis","volume":"201","author":"Coras R.","year":"2018","journal-title":"Transl Res"},{"issue":"2","key":"14","article-title":"Circulating free DNA and its emerging role in autoimmune diseases","volume":"11","author":"Mondelo-Mada P.","year":"2021","journal-title":"J Pers Med"},{"issue":"18","key":"15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186827","article-title":"Circulating cell-free nucleic acids: Main characteristics and clinical application","volume":"21","author":"Szilagyi M.","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"16","first-page":"139","article-title":"Free DNA in the serum of rheumatoid arthritis patients","volume":"4","author":"Leon S.A.","year":"1977","journal-title":"J Rheumatol"},{"issue":"9","key":"17","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1373\/clinchem.2006.084509","article-title":"Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis","volume":"53","author":"Zhong X.Y.","year":"2007","journal-title":"Clin Chem"},{"issue":"1","key":"18","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1295-z","article-title":"Circulating DNA in rheumatoid arthritis: Pathological changes and association with clinically used serological markers","volume":"19","author":"Rykova E.","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/1756-185X.12959","article-title":"Circulating cell free DNA: A marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis","volume":"20","author":"Hashimoto T.","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00662","article-title":"Identification of specific joint-inflammatogenic cell-free DNA molecules from synovial fluids of patients with rheumatoid arthritis","volume":"11","author":"Dong C.","year":"2020","journal-title":"Frontiers Immunol"},{"issue":"8","key":"21","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00296-018-4055-8","article-title":"Anti-cytokine therapy and plasma DNA in patients with rheumatoid arthritis","volume":"38","author":"Laukova L.","year":"2018","journal-title":"Rheumatol Int"},{"issue":"1-2","key":"22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13317-015-0066-6","article-title":"Decreased serum cell-free DNA levels in rheumatoid arthritis","volume":"6","author":"Dunaeva M.","year":"2015","journal-title":"Auto Immun Highlights"},{"issue":"9","key":"23","doi-asserted-by":"publisher","DOI":"10.3390\/cells8090953","article-title":"DNA methylation as a future therapeutic and diagnostic target in rheumatoid arthritis","volume":"8","author":"Ciechomska M.","year":"2019","journal-title":"Cells"},{"issue":"7639","key":"24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao D.A.","year":"2017","journal-title":"Nature"},{"issue":"9","key":"25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrrheum.2015.71","article-title":"Immune cell profiling to guide therapeutic decisions in rheumatic diseases","volume":"11","author":"Ermann J.","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"3-4","key":"26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaut.2009.02.012","article-title":"MicroRNA in autoimmunity and autoimmune diseases","volume":"32","author":"Pauley K.M.","year":"2009","journal-title":"J Autoimmun"},{"issue":"1","key":"27","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-1178-8","article-title":"Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis","volume":"18","author":"Withrow J.","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"28","article-title":"Emerging molecular markers towards potential piagnostic panels for pupus","volume":"12","author":"Tan G.","year":"2021","journal-title":"Front Immunol"},{"issue":"9","key":"29","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer M.","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"30","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/art.40452","article-title":"Review: Cell death, nucleic acids, and emmunity: Inflammation beyond the grave","volume":"70","author":"Elkon K.B.","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.96.3.464","article-title":"Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus","volume":"96","author":"Tan E.M.","year":"1966","journal-title":"J Immunol"},{"issue":"9","key":"32","first-page":"983","article-title":"Characteristic parameters of the population of circulating DNA in cases of disseminated lupus erythematosus","volume":"34","author":"Willcox G.","year":"1986","journal-title":"Pathol Biol"},{"issue":"6","key":"33","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI109992","article-title":"Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus","volume":"66","author":"Raptis L.","year":"1980","journal-title":"J Clin Invest"},{"issue":"6","key":"34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/ard.40.6.593","article-title":"Measurement of plasma DNA by a physiochemical method: Relevance in SLE","volume":"40","author":"Klemp P.","year":"1981","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4049\/jimmunol.133.1.213","article-title":"Nuclear DNA degradation in lymphocytes of patients with systemic lupus erythematosus","volume":"133","author":"Compton L.J.","year":"1984","journal-title":"J Immunol"},{"issue":"1","key":"36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1172\/JCI114716","article-title":"Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone","volume":"86","author":"Rumore P.M.","year":"1990","journal-title":"J Clin Invest"},{"issue":"1","key":"37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/art.1780160108","article-title":"Detection of circulating DNA by counterimmunoelectrophoresis (CIE)","volume":"16","author":"Davis G.L.","year":"1973","journal-title":"Arthritis Rheum"},{"issue":"4","key":"38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/08916930701356317","article-title":"Sensitive detection of plasma\/serum DNA in patients with systemic lupus erythematosus","volume":"40","author":"Chen J.A.","year":"2007","journal-title":"Autoimmunity"},{"key":"39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00502","article-title":"Cell-free DNA as a biomarker in autoimmune rheumatic diseases","volume":"10","author":"Duvvuri B.","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2362.2010.02435.x","article-title":"Analysing cell-free plasma DNA and SLE disease activity","volume":"41","author":"Atamaniuk J.","year":"2011","journal-title":"Eur J Clin Invest"},{"issue":"24","key":"41","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2169\/internalmedicine.53.2570","article-title":"Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus","volume":"53","author":"Zhang S.","year":"2014","journal-title":"Intern Med"},{"issue":"11","key":"42","article-title":"High levels of circulating cell-free DNA are a biomarker of active SLE","volume":"48","author":"Xu Y.","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2018.04.016","article-title":"Dysregulation of microRNAs in autoimmune diseases: Patho-genesis, biomarkers and potential therapeutic targets","volume":"428","author":"Long H.","year":"2018","journal-title":"Cancer Lett"},{"issue":"3","key":"44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.trsl.2012.04.002","article-title":"Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus","volume":"160","author":"Wang H.","year":"2012","journal-title":"Transl Res"},{"issue":"5","key":"45","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.37890","article-title":"Circulating microRNA expression profiles associated with systemic lupus erythematosus","volume":"65","author":"Carlsen A.L.","year":"2013","journal-title":"Arthritis Rheumat"},{"issue":"3","key":"46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10067-011-1857-4","article-title":"Expression of miR-146a and miR-155 in the urinary sediment of systemic associated with systemic lupus erythematosus","volume":"31","author":"Wang G.","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"1","key":"47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/0961203318801673","article-title":"Primary Sjogren's syndrome","volume":"27","author":"Bowman S.J.","year":"2018","journal-title":"Lupus"},{"key":"48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clim.2017.04.005","article-title":"Sjogren's syndrome: Clinical aspects","volume":"182","author":"Vivino F.B.","year":"2017","journal-title":"Clin Immunol"},{"issue":"9","key":"49","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/0961203311399606","article-title":"Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjogren's syndrome","volume":"20","author":"Bartoloni E.","year":"2011","journal-title":"Lupus"},{"issue":"22","key":"50","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1007\/s00216-019-01969-x","article-title":"SERS-based liquid biopsy of saliva and serum from patients with Sjogren's syndrome","volume":"411","author":"Stefancu A.","year":"2019","journal-title":"Anal Bioanal Chem"},{"key":"51","article-title":"Proteomics of saliva, plasma, and salivary gland tissue in Sjogren's syndrome and non-Sjogren patients identify novel biomarker candidates","volume":"225","author":"Sembler-Maller M.L.","year":"2020","journal-title":"J Proteom"},{"issue":"1","key":"52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-019-1961-4","article-title":"Proteomic and histopathological characterisation of sicca subjects and primary Sjogren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers","volume":"21","author":"Aqrawi L.A.","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"53","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1007\/s12035-016-0235-2","article-title":"Circulating microRNA profiles as liquid biopsies for the characterization and diagnosis of fibromyalgia syndrome","volume":"54","author":"Masotti A.","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"1","key":"54","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000870","article-title":"Window of opportunity in rheumatoid arthritis. Definitions and supporting evidence: From old to new perspectives","volume":"5","author":"Burgers L.E.","year":"2019","journal-title":"RMD Open"},{"issue":"1","key":"55","doi-asserted-by":"publisher","DOI":"10.1186\/s12014-020-09292-9","article-title":"Proteomic analysis of synovial fluid from rheumatic arthritis and spondyloarthritis patients","volume":"17","author":"Birkelund S.","year":"2020","journal-title":"Clin Proteom"},{"issue":"7","key":"56","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nrneph.2016.71","article-title":"The role of neutrophils and NETosis in autoimmune and renal diseases","volume":"12","author":"Gupta S.","year":"2016","journal-title":"Nat Rev Nephrol"}],"container-title":["Critical Reviews in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/56d4ad8e2e37ad2b\/CRI-45288 Final.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:02:43Z","timestamp":1676372563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/2ff21abf44b19838,099fd22c59c42610,56d4ad8e2e37ad2b.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevimmunol.2022045288","relation":{},"ISSN":["1040-8401"],"issn-type":[{"value":"1040-8401","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}